Atlas of transgenic Tet-Off Ca2+/calmodulin-dependent protein kinase II and prion protein promoter activity in the mouse brain
Graphical abstract
Research Highlights
►The PrP and CamKII promoter mouse lines are popular (Tet-Off) conditional models ►We present an online atlas of Tet-Off promoter activity distributions in the brain ►A dual viewer tool facilitates comparison of PrP and CamKII promoter activity ►Tet-Off CamKII and PrP promoter activity distributions are largely complementary ►The atlas facilitates goal-directed generation of inducible transgenic mouse models
Introduction
Transgenic animal models allowing conditional regulation of gene expression are powerful tools for experimental investigation of neurodegenerative diseases (Lewandoski, 2001). A frequently used binary transgenic system is the tetracycline responsive gene (Tet-Off) system, in which transgene expression is activated or silenced by administration of tetracycline, or its derivatives (Gossen et al., 1995, Gossen and Bujard, 1992, Lewandoski, 2001). For brain-specific expression, conditional models using the Tet-Off system are currently mainly based on two transgenic mouse lines, either the prion protein (PrP)- or the Ca2+/calmodulin-dependent protein kinase II (CamKII) promoter mouse line. The PrP promoter line has been successfully used in several studies of various diseases, including prion diseases (Safar et al., 2005, Tremblay et al., 1998), Parkinson's disease (Nuber et al., 2008), analysis of alcohol consumption (Choi et al., 2002), spinocerebellar ataxia type 3 (Boy et al., 2009), and neurofilament transport (Millecamps et al., 2007). The CamKII promoter line has been used for the investigation of synaptic plasticity, learning and memory consolidation (Bukalo et al., 2004, Limback-Stokin et al., 2004, Mayford et al., 1997, Wood et al., 2005), neurodevelopmental disorders (Alvarez-Saavedra et al., 2007, Jerecic et al., 2001), and for the generation of transgenic mouse models for Alzheimer's disease (Jankowsky et al., 2005), Huntington's disease (Yamamoto et al., 2000), Parkinson's disease (Nuber et al., 2008), neocortical degeneration (Muyllaert et al., 2008), schizophrenia (Pletnikov et al., 2008), and neurofibromatosis (Saito et al., 2007).
Since the expression of the responder gene is dictated by the activity of the promoter construct, knowledge about the anatomical distribution of promoter activity is critical both for the successful generation of an inducible disease model, as well as for the interpretation of observations made in conditional models based on the PrP or CamKII promoters (Chen et al., 1998, Furth et al., 1994, Yamamoto et al., 2000). A priori insight in these anatomical distributions is therefore valuable for researchers constructing or using inducible Tet-Off models. CamKII is known as a forebrain specific promoter while the PrP promoter activity is mainly distributed in the brainstem and cerebellum (Bailly et al., 2004, Boy et al., 2006, Bukalo et al., 2004, Chen et al., 1998, Ghavami et al., 1999, Liang et al., 1996, Liu et al., 2001, Mantamadiotis et al., 2002, Mayford et al., 1995, Mayford et al., 1996, Tremblay et al., 1998, Alvarez-Saavedra et al., 2007, Yamamoto et al., 2000). At the cellular level, CamKII promoter activity is neuron specific and has not been reported in glia (Bukalo et al., 2004, Chen et al., 1998, Mayford et al., 1996, Mayford et al., 1997, Michalon et al., 2005, Alvarez-Saavedra et al., 2007), whereas PrP promoter activity is seen in both neuronal and glia cell populations (Boy et al., 2006, Boy et al., 2009, Gotz et al., 2001). Using double-transgenic mice with the LacZ reporter gene (encoding the enzymatically detectable β-galactosidase) as a responder, we have performed comprehensive brain-wide mapping of promoter activity at the level of regions and cells in PrP/LacZ (Boy et al., 2006) and CamKII/LacZ mice (present study).
We have previously published a detailed online atlas of the distribution of PrP promoter regulated gene expression (Boy et al., 2006). Building upon this technology, we here present a similar atlas of CamKII promoter-regulated gene expression distributions across the entire mouse brain. We further present a novel atlas application tailored for direct comparison of corresponding histological section images showing PrP and CamKII promoter activity. We report largely complementary distributions of PrP and CamKII promoter activity throughout the entire brain and discuss distributions in selected example regions in more detail. Thus, our online atlas of comprehensive promoter activity pattern in both the Tet-Off PrP and CamKII promoter mouse line will benefit future planning of experiments and goal-directed generation of specific conditional animal models as well as the interpretation of findings from such animals.
Section snippets
Materials and methods
To map the distribution of Tet-Off CamKII promoter activity in the mouse brain, two 40-week-old adult female CamKII/LacZ mice were used. In addition, to compare the CamKII and PrP Tet-Off promoter mouse lines, image material from our published atlas of Tet-Off PrP promoter-regulated gene expression (Boy et al., 2006) was re-used. For both promoter lines, images from two age-matched control animals (one LacZ, and one wild-type, both of the C57BL/6 strain; Boy et al., 2006) were used. All animal
Animal groups and identification of CamKII and PrP promoter regulated gene expression
In the double transgenic mice, presence of β-galactosidase (reflecting CamKII or PrP promoter activity leading to expression of the LacZ gene) was visualized as a distinct blue labeling using X-gal (5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside) as a substrate (Fig. 2, Fig. 3, Fig. 4). We investigated the distribution of X-gal labeling in brains from (1) two adult 40-week-old female CamKII/LacZ mice, (2) two adult 5-week-old female PrP/LacZ mice (previously reported in Boy et al., 2006), and
Discussion
To characterize and compare the brain-wide spatial distributions of inducible promoter activity in the two most commonly used Tet-Off promoter mouse lines, CamKII and PrP, we have developed a novel atlas tool tailored for side-by-side comparison of spatially corresponding histological section images from the two promoter models. Building upon our earlier atlas of PrP promoter activity (http://www.rbwb.org, Boy et al., 2006), we have constructed a similar atlas of CamKII promoter activity,
Acknowledgments
This research was supported by the Fritz Thyssen Stiftung and the European Union (6th Framework Programme, EUROSCA) to O.R., the Deutsche Heredo-Ataxie Gesellschaft to O.R. and T.S., The Research Council of Norway to J.G.B. and T.B.L., and EC grant QLG3-CT-2001-02256 to J.G.B. The sponsors had no influence on the design, execution or publication of the study. We thank I.A. Moene, A.T. Bore, and J.O. Kjode for expert technical assistance, and S.B. Prusiner, D. Westaway, M. Scott, P. Tremblay, K.
References (52)
- et al.
The three-dimensional organization of the hippocampal formation: a review of anatomical data
Neuroscience
(1989) Inter- and intra-laminar connections of pyramidal cells in the neocortex
Neurosci. Res.
(2005)- et al.
Database and tools for analysis of topographic organization and map transformations in major projection systems of the brain
Neuroscience
(2005) - et al.
Expression mapping of tetracycline-responsive prion protein promoter: digital atlasing for generating cell-specific disease models
Neuroimage
(2006) - et al.
Impaired NMDA receptor function in mouse olfactory bulb neurons by tetracycline-sensitive NR1 (N598R) expression
Brain Res. Mol. Brain Res.
(2001) - et al.
Striatal interneurones: chemical, physiological and morphological characterization
Trends Neurosci.
(1995) - et al.
Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies
Brain Res.
(2001) - et al.
CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP
Cell
(1995) - et al.
Memory and behavior: a second generation of genetically modified mice
Curr. Biol.
(1997) - et al.
Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration
Am. J. Pathol.
(2008)
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Brain Res. Brain Res. Rev.
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
Cell
Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis
Hum. Mol. Genet.
Hippocampal neuroanatomy
Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain
J. Comp. Neurol.
Co-regulation of two gene activities by tetracycline via a bidirectional promoter
Nucleic Acids Res.
Three-dimensional computerized reconstruction from serial sections: cells populations, regions, and whole brain
Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
Hum. Mol. Genet.
Conditional ablation of the neural cell adhesion molecule reduces precision of spatial learning, long-term potentiation, and depression in the CA1 subfield of mouse hippocampus
J. Neurosci.
In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain
J. Neurosci.
Detection of beta-galactosidase and alkaline phosphatase activities in tissue
Transgenic animals with inducible, targeted gene expression in brain
Mol. Pharmacol.
Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice
J. Neurosci.
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
Proc. Natl Acad. Sci. USA
Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons
J. Cell Sci.
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
Proc. Natl Acad. Sci. USA
Cited by (20)
Increased Signaling via Adenosine A<inf>1</inf>Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a
2015, NeuronCitation Excerpt :Thereafter, mice were either further kept on doxycycline or without doxycycline for 4 weeks to allow transgene expression. The characterization of the spatial distribution of the transgene expression, using immunohistochemical staining against the reporter gene, revealed that the mCherry expression has a labeling pattern typical for CaMKII promoter activity, primary distributed to forebrain neurons, similar to the previous reports (Mayford et al., 1996; Odeh et al., 2011) (Figure 1B). The evaluation of the doxycycline-regulated transgene expression demonstrated that doxycycline treatment completely suppressed the mCherry immunofluorescence labeling (Figure S3A) and mRNA and protein expression in the brain to undetectable levels (Figures 1D and S3B).
Genetic Models of Parkinson's Disease: Behavior, Signaling, and Pathological Features
2015, Environmental Factors in Neurodevelopmental and Neurodegenerative DisordersNew Transgenic Technologies
2015, Movement Disorders: Genetics and Models: Second EditionBrainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
2014, Neurobiology of AgingCitation Excerpt :With the virtual microcopy tool embedded in the web application (Fig. 4C), the user can browse section images across the brain and select any image for detailed inspection of the Aβx-40 immunolabeling. We believe that by providing comprehensive information about transgenic animal models available through this type of neuroinformatics resource (Boy et al., 2006; Odeh et al., 2011), it will be possible to make more informed decisions on choice of animal model and study design. The tg-ArcSwe mouse model is practical to use considering the early onset of extracellular plaque formation.
Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter
2014, Journal of Neuroscience MethodsCitation Excerpt :Although transgenic mice expressing transgenes driven by the SynI promoter have been generated (Hoesche et al., 1993), its weak transcriptional activity, which is a common feature of cell type-specific promoters, often yields ambiguous outcomes. To avoid ambiguity, a tetracycline-controlled transactivation system (Gossen and Bujard, 1992; Odeh et al., 2011) has been used to compensate for the insufficient transcriptional activity of the SynI promoter (Chen et al., 2013; Kuhn et al., 2012; Sargeant et al., 2012). However, a several studies have demonstrated the toxicity of the tetracycline transactivator (McCloskey et al., 2005; Morimoto and Kopan, 2009; Sisson et al., 2006), which sometimes influences the phenotypes of the resultant transgenic rodents, including their behavior (Barton et al., 2002; Han et al., 2012).
Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability
2012, Behavioural Brain ResearchCitation Excerpt :The major brain areas involved in contextual and cued fear conditioning include the amygdala, hippocampus, frontal cortex, and cingulate cortex. Although there is evidence that amygdala activity, especially the basolateral amygdala, is not necessary for associative learning due to contextual fear conditioning [44–47], the heterogeneous distribution of CamKII promoter activity within the basolateral complex, central nuclei, and the amygdalo–hippocampal area [48,49] does not exclude the amygdala as contributing to the behavioral phenotype in the CamKIIcre/+, crbn−/− mice. Heterozygous CamKIIcre/+, crbn+/− mice do not exhibit any overt abnormalities on the behavioral tests performed in this study suggesting that the expression a single crbn allele in the mouse forebrain is not sufficient to cause deficits in HPC-dependent memory, motor function, exploratory motivation, or affective behaviors.